19 May 2013
Keywords: gilead, files, hep, drug, adefovir, eu/usa, sciences
Article | 01 April 2002
Gilead Sciences has submitted its chronic hepatitis B treatment,adefovir dipivoxil 10mg, to the European Medicines Evaluation Agency,
just a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 2002
6 May 2002
17 May 2013
© 2013 thepharmaletter.com